Jeffrey C Pearson (J C Pearson)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Rheumatoid Arthritis Patients

Methicillin Resistant Staphylococcus Aureus

Acute Kidney Injury

Top Venues

Open forum infectious diseases

JAC-antimicrobial resistance

Antibiotics (Basel, Switzerland)

The Annals of pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Christo Cimino, Christina G Rivera, Jeffrey C Pearson, Benjamin Colton, Douglas Slain, Monica V Mahoney
Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians. Open forum infectious diseases 11 (4) (2024)
Christo Cimino, Christina G Rivera, Jeffrey C Pearson, Benjamin Colton, Douglas Slain, Monica V Mahoney
Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians. Open forum infectious diseases 11 (4) (2024)
Skyler Starkel, Melanie Goodberlet, Brian Schuler, Alex Rock, Jeremy R DeGrado, Jeffrey C Pearson
Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditis. JAC-antimicrobial resistance 6 (1) (2023)
Skyler Starkel, Melanie Goodberlet, Brian Schuler, Alex Rock, Jeremy R DeGrado, Jeffrey C Pearson
Evaluating the incidence of acute kidney injury and gentamicin synergy dosing for endocarditis. JAC-antimicrobial resistance 6 (1) (2023)
Rachel S Britt, Jeffrey C Pearson, Mary T Lasalvia, Monica V Mahoney, Christopher McCoy, Simi Padival
Impact of a pharmacy resident on a transitions of care rotation for inpatients enrolled in an outpatient parenteral antimicrobial therapy (OPAT) program. Antimicrobial stewardship & healthcare epidemiology : ASHE 3 (1) (2023)
Maha S Assadoon, Jeffrey C Pearson, David W Kubiak, Mary P Kovacevic, Brandon W Dionne
Evaluation of Vancomycin Accumulation in Patients With Obesity. Open forum infectious diseases 9 (10) (2022)
Yazed Saleh Alsowaida, David W Kubiak, Brandon Dionne, Mary P Kovacevic, Jeffrey C Pearson
Vancomycin Area under the Concentration-Time Curve Estimation Using Bayesian Modeling versus First-Order Pharmacokinetic Equations: A Quasi-Experimental Study. Antibiotics (Basel, Switzerland) 11 (9) (2022)
Brittany N Weber, Guohai Zhou, Andy Kim, Jeffrey C Pearson, John Stone, Marcelo DiCarli, Sarah Nikiforow, Ann Woolley
Impact of Interleukin-6 Receptor Blockade With Tocilizumab on Cardiac Injury in Patients With COVID-19: A Retrospective Cohort Study. Open forum infectious diseases 8 (2) (2021)
Jeffrey C Pearson, Brandon Dionne, Aaron Richterman, Samuel J Vidal, Zoe Weiss, Gustavo E Velásquez, Francisco M Marty, Paul E Sax, Sigal Yawetz
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series. Open forum infectious diseases 7 (10) (2020)
J A Johnson, Jeffrey C Pearson, D W Kubiak, B Dionne, S E Little, D R Wesemann
Treatment of Chronic Granulomatous Disease-Related Pulmonary Aspergillus Infection in Late Pregnancy. Open forum infectious diseases 7 (10) (2020)
Rachel S Britt, Jeffrey C Pearson, Monica V Mahoney, Alexa A Carlson
Ceftaroline-Induced Thrombocytopenia: A Case Report. The Annals of pharmacotherapy 53 (7) (2019)